|Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)|
A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ...
Aids 16 (3), 369-379, 2002
|Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …|
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
|Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy|
A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ...
Aids 15 (12), 1483-1491, 2001
|The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation …|
LM Larocca, D Capello, A Rinelli, S Nori, A Antinori, A Gloghini, ...
Blood 92 (3), 1011-1019, 1998
|Patient-reported nonadherence to HAART is related to protease inhibitor levels.|
R Murri, A Ammassari, K Gallicano, AL De, A Cingolani, D Jacobson, ...
Journal of acquired immune deficiency syndromes (1999) 24 (2), 123-128, 2000
|A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1 infected patients|
K Van Laethem, A De Luca, A Antinori, A Cingolani, CF Perna, ...
Antiviral therapy 7 (2), 123-130, 2002
|Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry …|
A Antinori, A Cingolani, P Lorenzini, ML Giancola, I Uccella, S Bossolasco, ...
Journal of neurovirology 9 (1), 47-53, 2003
|Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure|
A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ...
AIDS research and human retroviruses 18 (12), 835-838, 2002
|Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS …|
A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ...
Journal of Clinical Oncology 17 (2), 554-554, 1999
|Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis|
C Romagnoli, S Frezza, A Cingolani, A De Luca, M Puopolo, ...
European journal of pediatrics 160 (6), 345-350, 2001
|AIDS-related focal brain lesions in the era of highly active antiretroviral therapy|
A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ...
Neurology 55 (8), 1194-1200, 2000
|Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.|
E Girardi, F Palmieri, A Cingolani, A Ammassari, N Petrosillo, L Gillini, ...
Journal of acquired immune deficiency syndromes (1999) 26 (4), 326-331, 2001
|Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy|
A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ...
Clinical infectious diseases 39 (11), 1681-1691, 2004
|Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma|
A Cingolani, A De Luca, A Ammassari, A Antinori, L Ortona, LM Larocca, ...
JNCI: Journal of the National Cancer Institute 90 (5), 364-369, 1998
|The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy|
A De Luca, ML Giancola, A Ammassari, S Grisetti, MG Paglia, M Gentile, ...
The Journal of infectious diseases 182 (4), 1077-1083, 2000
|Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis|
A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ...
Aids 22 (14), 1759-1767, 2008
|Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance|
A De Luca, A Cingolani, S Di Giambenedetto, MP Trotta, F Baldini, ...
The Journal of infectious diseases 187 (12), 1934-1943, 2003
|Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent …|
A Marzocchetti, S Di Giambenedetto, A Cingolani, A Ammassari, R Cauda, ...
Journal of clinical microbiology 43 (8), 4175-4177, 2005
|Evaluation of cerebrospinal fluid EBV‐DNA and IL‐10 as markers for in vivo diagnosis of AIDS‐related primary central nervous system lymphoma|
AD Luca, A Antinori, A Cingolani, LM Larocca, A Linzalone, A Ammassari, ...
British journal of haematology 90 (4), 844-849, 1995
|CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study|
C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ...
The lancet HIV 2 (3), e98-e106, 2015